πŸ‡ΊπŸ‡Έ FDA
Patent

US 12150995

IRAK degraders and uses thereof

granted A61KA61K47/545A61K47/55

Quick answer

US patent 12150995 (IRAK degraders and uses thereof) held by Kymera Therapeutics, Inc. expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Kymera Therapeutics, Inc.
Grant date
Tue Nov 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K47/545, A61K47/55, A61P, A61P35/00